PulseHaler Drug Deposition Study in Chronic Obstructive Pulmonary Disease Patients

NCT01187589 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

15

Enrollment

INDUSTRY

Sponsor class

Conditions

COPD

Interventions

DEVICE: Pulsehaler
DRUG: Nebulizer & Albuterol 0.5ml

Sponsor

Respinova LTD